nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—COMT—telencephalic ventricle—malignant glioma	0.0792	0.231	CbGeAlD
Dobutamine—COMT—brainstem—malignant glioma	0.0214	0.0626	CbGeAlD
Dobutamine—COMT—telencephalon—malignant glioma	0.019	0.0556	CbGeAlD
Dobutamine—ADRB1—telencephalon—malignant glioma	0.0161	0.0471	CbGeAlD
Dobutamine—COMT—medulla oblongata—malignant glioma	0.0149	0.0437	CbGeAlD
Dobutamine—CA2—embryo—malignant glioma	0.0145	0.0424	CbGeAlD
Dobutamine—COMT—midbrain—malignant glioma	0.0137	0.0399	CbGeAlD
Dobutamine—COMT—spinal cord—malignant glioma	0.0133	0.0389	CbGeAlD
Dobutamine—CA2—brainstem—malignant glioma	0.0133	0.0389	CbGeAlD
Dobutamine—CA2—retina—malignant glioma	0.0128	0.0375	CbGeAlD
Dobutamine—CA2—telencephalon—malignant glioma	0.0118	0.0345	CbGeAlD
Dobutamine—CA5B—central nervous system—malignant glioma	0.0117	0.0343	CbGeAlD
Dobutamine—COMT—central nervous system—malignant glioma	0.0108	0.0316	CbGeAlD
Dobutamine—COMT—cerebellum—malignant glioma	0.0106	0.0309	CbGeAlD
Dobutamine—CA5B—brain—malignant glioma	0.00931	0.0272	CbGeAlD
Dobutamine—CA2—medulla oblongata—malignant glioma	0.00928	0.0271	CbGeAlD
Dobutamine—ADRB1—central nervous system—malignant glioma	0.00915	0.0267	CbGeAlD
Dobutamine—COMT—brain—malignant glioma	0.00858	0.0251	CbGeAlD
Dobutamine—CA2—midbrain—malignant glioma	0.00848	0.0248	CbGeAlD
Dobutamine—CA2—spinal cord—malignant glioma	0.00828	0.0242	CbGeAlD
Dobutamine—ADRB1—brain—malignant glioma	0.00727	0.0212	CbGeAlD
Dobutamine—CA2—central nervous system—malignant glioma	0.00671	0.0196	CbGeAlD
Dobutamine—CA2—cerebellum—malignant glioma	0.00656	0.0192	CbGeAlD
Dobutamine—CA2—brain—malignant glioma	0.00533	0.0156	CbGeAlD
Dobutamine—CA2—Metabolism—BCHE—malignant glioma	0.000887	0.00135	CbGpPWpGaD
Dobutamine—CA2—Metabolism—SLC5A5—malignant glioma	0.000876	0.00133	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CCR4—malignant glioma	0.000869	0.00132	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTT1—malignant glioma	0.000853	0.0013	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CCR4—malignant glioma	0.00085	0.00129	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000807	0.00123	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS1—malignant glioma	0.0008	0.00122	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CAV1—malignant glioma	0.0008	0.00122	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00079	0.0012	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCR4—malignant glioma	0.000789	0.0012	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCR4—malignant glioma	0.000772	0.00117	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CAV1—malignant glioma	0.000746	0.00113	CbGpPWpGaD
Dobutamine—COMT—Metabolism—BCHE—malignant glioma	0.000743	0.00113	CbGpPWpGaD
Dobutamine—COMT—Metabolism—SLC5A5—malignant glioma	0.000734	0.00112	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CG—malignant glioma	0.000728	0.00111	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTP1—malignant glioma	0.000706	0.00107	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARG—malignant glioma	0.000703	0.00107	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CAT—malignant glioma	0.000687	0.00104	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CG—malignant glioma	0.00068	0.00103	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MDK—malignant glioma	0.000673	0.00102	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MDK—malignant glioma	0.000658	0.001	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARG—malignant glioma	0.000656	0.000998	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NCOR1—malignant glioma	0.000649	0.000986	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCR3—malignant glioma	0.000646	0.000982	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DTX1—malignant glioma	0.000642	0.000976	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CD—malignant glioma	0.00064	0.000973	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCR3—malignant glioma	0.000632	0.000961	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DTX1—malignant glioma	0.000628	0.000955	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—F2—malignant glioma	0.000615	0.000935	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—F2—malignant glioma	0.000602	0.000914	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CD—malignant glioma	0.000598	0.000909	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTP1—malignant glioma	0.000591	0.000899	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000591	0.000898	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCR3—malignant glioma	0.000587	0.000892	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—BDKRB2—malignant glioma	0.000578	0.000879	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CAT—malignant glioma	0.000576	0.000875	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCR3—malignant glioma	0.000574	0.000873	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000569	0.000865	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CB—malignant glioma	0.000558	0.000848	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000557	0.000846	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—malignant glioma	0.000553	0.000841	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NCOR1—malignant glioma	0.000544	0.000826	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—KNG1—malignant glioma	0.000538	0.000817	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—BDKRB2—malignant glioma	0.000537	0.000816	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CAV1—malignant glioma	0.000529	0.000804	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—KNG1—malignant glioma	0.000526	0.0008	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—BDKRB2—malignant glioma	0.000525	0.000798	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CB—malignant glioma	0.000521	0.000792	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—malignant glioma	0.000516	0.000785	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SUFU—malignant glioma	0.00051	0.000775	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HEY2—malignant glioma	0.000504	0.000766	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SUFU—malignant glioma	0.000499	0.000758	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HEY2—malignant glioma	0.000493	0.000749	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GFAP—malignant glioma	0.000492	0.000748	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KNG1—malignant glioma	0.000488	0.000742	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTEN—malignant glioma	0.000482	0.000733	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CG—malignant glioma	0.000482	0.000732	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GFAP—malignant glioma	0.000481	0.000732	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KNG1—malignant glioma	0.000478	0.000726	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPHK1—malignant glioma	0.000476	0.000724	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HEY1—malignant glioma	0.000466	0.000709	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR4—malignant glioma	0.000466	0.000709	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPHK1—malignant glioma	0.000466	0.000708	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—malignant glioma	0.000465	0.000707	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HEY1—malignant glioma	0.000456	0.000694	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR4—malignant glioma	0.000456	0.000694	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HIST1H3B—malignant glioma	0.000453	0.000689	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTEN—malignant glioma	0.00045	0.000684	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HIST1H3B—malignant glioma	0.000443	0.000674	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CAV1—malignant glioma	0.000443	0.000674	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CXCL8—malignant glioma	0.000433	0.000659	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MMP3—malignant glioma	0.000433	0.000658	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CXCL8—malignant glioma	0.000424	0.000644	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CD—malignant glioma	0.000423	0.000644	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MMP3—malignant glioma	0.000423	0.000643	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JAG2—malignant glioma	0.000414	0.000629	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JAG2—malignant glioma	0.000405	0.000615	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CG—malignant glioma	0.000404	0.000614	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—malignant glioma	0.00039	0.000592	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CB—malignant glioma	0.000369	0.000561	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—malignant glioma	0.000366	0.000556	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CD—malignant glioma	0.000355	0.000539	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—H3F3A—malignant glioma	0.00035	0.000532	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—F2—malignant glioma	0.000348	0.000528	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCR3—malignant glioma	0.000347	0.000527	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—H3F3A—malignant glioma	0.000342	0.00052	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CA—malignant glioma	0.00034	0.000517	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—F2—malignant glioma	0.00034	0.000517	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCR3—malignant glioma	0.000339	0.000515	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—YWHAE—malignant glioma	0.000337	0.000513	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NTRK2—malignant glioma	0.000337	0.000513	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FLT1—malignant glioma	0.000336	0.00051	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DUSP6—malignant glioma	0.000334	0.000508	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000333	0.000506	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JAG1—malignant glioma	0.00033	0.000502	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NTRK2—malignant glioma	0.00033	0.000501	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—YWHAE—malignant glioma	0.00033	0.000501	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH3—malignant glioma	0.000329	0.0005	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FLT1—malignant glioma	0.000328	0.000499	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DUSP6—malignant glioma	0.000327	0.000497	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000325	0.000495	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FBXW7—malignant glioma	0.000323	0.000491	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JAG1—malignant glioma	0.000323	0.000491	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	0.000321	0.000489	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTEN—malignant glioma	0.000319	0.000485	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CA—malignant glioma	0.000318	0.000483	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BDKRB2—malignant glioma	0.000317	0.000482	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FBXW7—malignant glioma	0.000316	0.000481	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—F2—malignant glioma	0.000316	0.00048	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	0.00031	0.000471	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CB—malignant glioma	0.000309	0.00047	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—F2—malignant glioma	0.000309	0.000469	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—malignant glioma	0.000306	0.000466	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT2—malignant glioma	0.000304	0.000463	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CG—malignant glioma	0.000302	0.000459	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	0.000298	0.000452	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTPN11—malignant glioma	0.000297	0.000451	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	0.000295	0.000449	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH2—malignant glioma	0.000295	0.000448	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000292	0.000444	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	0.00029	0.000441	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KNG1—malignant glioma	0.000288	0.000438	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	0.000288	0.000438	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000286	0.000435	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KNG1—malignant glioma	0.000282	0.000429	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—malignant glioma	0.000278	0.000422	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT2—malignant glioma	0.000276	0.00042	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NTRK1—malignant glioma	0.000275	0.000418	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT2—malignant glioma	0.00027	0.000411	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NTRK1—malignant glioma	0.000269	0.000409	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTEN—malignant glioma	0.000267	0.000406	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CD—malignant glioma	0.000265	0.000404	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	0.00026	0.000395	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—malignant glioma	0.000259	0.000394	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP3—malignant glioma	0.000256	0.000388	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000255	0.000387	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	0.000253	0.000385	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP3—malignant glioma	0.00025	0.00038	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000249	0.000379	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	0.000248	0.000377	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTK2—malignant glioma	0.000246	0.000374	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	0.000245	0.000372	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HES1—malignant glioma	0.000242	0.000367	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTK2—malignant glioma	0.000241	0.000366	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NCOR1—malignant glioma	0.00024	0.000365	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	0.00024	0.000364	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—RAF1—malignant glioma	0.000237	0.00036	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HES1—malignant glioma	0.000236	0.000359	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NCOR1—malignant glioma	0.000235	0.000357	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—IL2—malignant glioma	0.000234	0.000356	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—RAF1—malignant glioma	0.000232	0.000352	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	0.000231	0.000352	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	0.00023	0.00035	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—IL2—malignant glioma	0.000229	0.000348	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	0.000226	0.000344	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	0.000225	0.000342	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CA—malignant glioma	0.000225	0.000342	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPP1—malignant glioma	0.000223	0.00034	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	0.000222	0.000338	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPP1—malignant glioma	0.000218	0.000332	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	0.000218	0.000331	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL2—malignant glioma	0.000213	0.000323	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TERT—malignant glioma	0.000212	0.000322	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL2—malignant glioma	0.000208	0.000316	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TERT—malignant glioma	0.000207	0.000315	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PDGFB—malignant glioma	0.000207	0.000314	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGFR1—malignant glioma	0.000206	0.000313	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HIF1A—malignant glioma	0.000202	0.000308	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDGFB—malignant glioma	0.000202	0.000307	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGFR1—malignant glioma	0.000201	0.000306	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HIF1A—malignant glioma	0.000198	0.000301	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CAV1—malignant glioma	0.000196	0.000298	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KDR—malignant glioma	0.000194	0.000294	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CAV1—malignant glioma	0.000192	0.000291	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KDR—malignant glioma	0.000189	0.000288	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CA—malignant glioma	0.000189	0.000287	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—F2—malignant glioma	0.000186	0.000283	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FN1—malignant glioma	0.000186	0.000283	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BAD—malignant glioma	0.000184	0.00028	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—malignant glioma	0.000184	0.000279	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	0.000182	0.000277	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—F2—malignant glioma	0.000182	0.000277	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FN1—malignant glioma	0.000182	0.000277	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BAD—malignant glioma	0.00018	0.000274	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CD80—malignant glioma	0.000179	0.000272	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	0.000178	0.000271	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	0.000178	0.000271	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APC—malignant glioma	0.000178	0.000271	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGF—malignant glioma	0.000176	0.000268	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTPN11—malignant glioma	0.000175	0.000266	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CD80—malignant glioma	0.000175	0.000266	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APC—malignant glioma	0.000175	0.000265	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	0.000175	0.000265	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGF—malignant glioma	0.000173	0.000262	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTPN11—malignant glioma	0.000171	0.000261	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BRAF—malignant glioma	0.000168	0.000255	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BRAF—malignant glioma	0.000164	0.000249	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT2—malignant glioma	0.000163	0.000248	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EGFR—malignant glioma	0.000163	0.000247	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT2—malignant glioma	0.00016	0.000243	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EGFR—malignant glioma	0.000159	0.000242	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	0.000157	0.000238	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000155	0.000236	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—malignant glioma	0.000154	0.000234	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KRAS—malignant glioma	0.000154	0.000233	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	0.000153	0.000233	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000152	0.000231	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KRAS—malignant glioma	0.00015	0.000228	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF2—malignant glioma	0.00015	0.000228	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF2—malignant glioma	0.000147	0.000223	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	0.000141	0.000214	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MDM2—malignant glioma	0.00014	0.000214	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RAF1—malignant glioma	0.00014	0.000213	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ERBB2—malignant glioma	0.000139	0.000211	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	0.000138	0.00021	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MDM2—malignant glioma	0.000137	0.000209	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RAF1—malignant glioma	0.000137	0.000208	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	0.000137	0.000208	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ERBB2—malignant glioma	0.000136	0.000206	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	0.000134	0.000203	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL8—malignant glioma	0.000131	0.0002	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL8—malignant glioma	0.000129	0.000195	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	0.000127	0.000193	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—malignant glioma	0.000126	0.000191	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL2—malignant glioma	0.000126	0.000191	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	0.000124	0.000189	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—malignant glioma	0.000123	0.000187	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL2—malignant glioma	0.000123	0.000187	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—malignant glioma	0.000119	0.000181	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTEN—malignant glioma	0.000118	0.00018	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—malignant glioma	0.000116	0.000177	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTEN—malignant glioma	0.000116	0.000176	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—malignant glioma	0.000115	0.000175	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—malignant glioma	0.000113	0.000171	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—malignant glioma	0.000107	0.000162	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT3—malignant glioma	0.000106	0.000161	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—malignant glioma	0.000104	0.000159	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT3—malignant glioma	0.000103	0.000157	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—malignant glioma	9.82e-05	0.000149	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—malignant glioma	9.6e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGFR—malignant glioma	9.6e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGFR—malignant glioma	9.39e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KRAS—malignant glioma	9.07e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KRAS—malignant glioma	8.87e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	8.33e-05	0.000127	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	8.15e-05	0.000124	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—malignant glioma	8.06e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—malignant glioma	7.89e-05	0.00012	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—malignant glioma	6.81e-05	0.000103	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—malignant glioma	6.66e-05	0.000101	CbGpPWpGaD
